Brainstorm Cell Therapeutics Inc. (BCLI)
NASDAQ: BCLI · IEX Real-Time Price · USD
0.346
-0.031 (-8.12%)
At close: Jul 19, 2024, 4:00 PM
0.340
-0.006 (-1.76%)
Pre-market: Jul 22, 2024, 4:00 AM EDT

BCLI Statistics

Total Valuation

BCLI has a market cap or net worth of $27.56 million. The enterprise value is $27.90 million.

Market Cap 27.56M
Enterprise Value 27.90M

Important Dates

The next estimated earnings date is Monday, August 12, 2024, before market open.

Earnings Date Aug 12, 2024
Ex-Dividend Date n/a

Share Statistics

BCLI has 79.58 million shares outstanding. The number of shares has increased by 76.23% in one year.

Shares Outstanding 79.58M
Shares Change (YoY) +76.23%
Shares Change (QoQ) +25.62%
Owned by Insiders (%) 9.05%
Owned by Institutions (%) 5.09%
Float 63.19M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.18

Current Ratio 0.18
Quick Ratio 0.12
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -27.82

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -327.30%
Return on Capital (ROIC) n/a
Revenue Per Employee n/a
Profits Per Employee -$535,655
Employee Count 29
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -80.87% in the last 52 weeks. The beta is 0.36, so BCLI's price volatility has been lower than the market average.

Beta (5Y) 0.36
52-Week Price Change -80.87%
50-Day Moving Average 0.44
200-Day Moving Average 0.36
Relative Strength Index (RSI) 39.95
Average Volume (20 Days) 497,878

Short Selling Information

The latest short interest is 1.47 million, so 1.85% of the outstanding shares have been sold short.

Short Interest 1.47M
Short Previous Month 890,588
Short % of Shares Out 1.85%
Short % of Float 2.32%
Short Ratio (days to cover) 2.19

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -18.76M
Pretax Income -15.53M
Net Income -15.53M
EBITDA -14.73M
EBIT -15.00M
Earnings Per Share (EPS) -$0.32
Full Income Statement

Balance Sheet

The company has $779,000 in cash and $1.12 million in debt, giving a net cash position of -$342,000 or -$0.00 per share.

Cash & Cash Equivalents 779,000
Total Debt 1.12M
Net Cash -342,000
Net Cash Per Share -$0.00
Equity (Book Value) -5.55M
Book Value Per Share -0.07
Working Capital -5.57M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$19.54 million and capital expenditures -$18,000, giving a free cash flow of -$19.55 million.

Operating Cash Flow -19.54M
Capital Expenditures -18,000
Free Cash Flow -19.55M
FCF Per Share -$0.30
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BCLI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -76.23%
Shareholder Yield -76.23%
Earnings Yield -56.37%
FCF Yield -70.95%

Analyst Forecast

The average price target for BCLI is $2.00, which is 477.53% higher than the current price. The consensus rating is "Strong Buy".

Price Target $2.00
Price Target Difference 477.53%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on September 16, 2014. It was a reverse split with a ratio of 1:15.

Last Split Date Sep 16, 2014
Split Type Reverse
Split Ratio 1:15

Scores

Altman Z-Score n/a
Piotroski F-Score 1